Branko Lazic
GG
Crvena Zvezda mts Belgrade
Returns to court
GCrvena Zvezda mts Belgrade
February 3, 2020
Lazic (illness) started and scored 12 points over 27 minutes in a domestic league game Monday.
ANALYSIS
Lazic was unable to participate in Red Star's last two EuroLeague games, but with him playing his regular role Monday, expect him to be back in the starting lineup for his club's next EuorLeague game Wednesday against Panathinaikos.
Read More News
Per Game
Total
Per 36
EuroLeague Per Game Stats
Loading Per Game Stats...
EuroLeague Total Stats
Loading Total Stats...
EuroLeague Per 36 Stats
Loading Per 36 Stats...
Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
DraftKings
Dream11
Loading Game Log...
Crvena Zvezda mts Belgrade Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Remains sidelined
GCrvena Zvezda mts Belgrade
Illness
January 31, 2020
Lazic (illness) will not play Friday against Efes, according to Crvena Zvezda's official Twitter account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
On track to return Friday
GCrvena Zvezda mts Belgrade
Illness
January 30, 2020
Lazic, who missed last week's game with an illness, is on track to return to action Friday against Efes, according to sportklub.rs.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Will not play Thursday
GCrvena Zvezda mts Belgrade
Undisclosed
January 22, 2020
Lazic will not play Thursday against Barcelona, according to Crvena Zvezda's official website.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Available for Round 13
GCrvena Zvezda mts Belgrade
December 12, 2019
Lazic (finger) is in uniform for Thursday's game against Baskonia, according to Crvena Zvezda's official Twitter account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Dealing with finger injury
GCrvena Zvezda mts Belgrade
Finger
December 5, 2019
Lazic did not play Thursday due to a finger injury, according to mondo.rs.
ANALYSIS
Subscribe now to instantly reveal our take on this news.